Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

546
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
546
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

940
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
940
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

285
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
285

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

GlucoseGo: a simple tool to predict hypoglycaemia during exercise in type 1 diabetes.

Diabetologia·2026
Same author

Continuous blood glucose monitoring prediction for diabetes using evolving neural network.

Scientific reports·2025
Same author

Impact of Recording Interval in Continuous Glucose Monitoring on Calculating the Metrics of Glycemic Control.

Journal of diabetes science and technology·2025
Same author

A User-Friendly Web Tool for Custom Analysis of Continuous Glucose Monitoring Data.

Journal of diabetes science and technology·2024

Related Experiment Video

Updated: Jul 6, 2025

The Immersive Cleveland Clinic Virtual Reality Shopping Platform for the Assessment of Instrumental Activities of Daily Living
08:36

The Immersive Cleveland Clinic Virtual Reality Shopping Platform for the Assessment of Instrumental Activities of Daily Living

Published on: July 28, 2022

3.8K

Virtual Reality Meets Diabetes.

Neil Vaughan1,2

  • 1Department of Clinical and Biomedical Science, NIHR Exeter Biomedical Research Centre, Exeter Centre of Excellence in Diabetes, University of Exeter, Exeter, UK.

Journal of Diabetes Science and Technology
|January 9, 2024
PubMed
Summary
This summary is machine-generated.

Virtual reality (VR) and augmented reality (AR) show promise in diabetes care, enhancing education, prevention, and treatment for all patients. Further innovation in VR diabetes tools can improve training and management.

Keywords:
augmented realitydiabetestrainingvirtual reality

More Related Videos

Author Spotlight: Enhancing Neurorehabilitation Through EEG, Motor Imagery, and Virtual Reality
10:14

Author Spotlight: Enhancing Neurorehabilitation Through EEG, Motor Imagery, and Virtual Reality

Published on: May 10, 2024

1.0K
Virtual Reality Experiments with Physiological Measures
07:09

Virtual Reality Experiments with Physiological Measures

Published on: August 29, 2018

12.7K

Related Experiment Videos

Last Updated: Jul 6, 2025

The Immersive Cleveland Clinic Virtual Reality Shopping Platform for the Assessment of Instrumental Activities of Daily Living
08:36

The Immersive Cleveland Clinic Virtual Reality Shopping Platform for the Assessment of Instrumental Activities of Daily Living

Published on: July 28, 2022

3.8K
Author Spotlight: Enhancing Neurorehabilitation Through EEG, Motor Imagery, and Virtual Reality
10:14

Author Spotlight: Enhancing Neurorehabilitation Through EEG, Motor Imagery, and Virtual Reality

Published on: May 10, 2024

1.0K
Virtual Reality Experiments with Physiological Measures
07:09

Virtual Reality Experiments with Physiological Measures

Published on: August 29, 2018

12.7K

Area of Science:

  • Digital Health
  • Medical Technology
  • Diabetes Management

Background:

  • Virtual reality (VR) and augmented reality (AR) are emerging technologies with significant potential in healthcare.
  • Their applications in diabetes management are increasingly being explored for various aspects of patient care and professional training.

Purpose of the Study:

  • To provide a comprehensive review of current virtual reality (VR) and augmented reality (AR) applications in diabetes.
  • To identify key application areas, future directions, and establish a foundation for developing novel VR tools for diabetes.
  • To compare features and benefits of existing VR diabetes applications.

Main Methods:

  • A thorough literature review of virtual reality for diabetes was conducted using multiple databases.
  • Features, benefits, and weaknesses of existing VR diabetes applications were analyzed.
  • A novel virtual reality diabetes tool prototype was developed and presented.

Main Results:

  • Three primary categories for VR in diabetes were identified: education, prevention, and treatment.
  • VR and AR applications demonstrate benefits for both Type 1 and Type 2 diabetes.
  • Target groups for VR in diabetes education include clinicians, adults, and children with diabetes.

Conclusions:

  • Virtual reality (VR) and augmented reality (AR) hold potential to significantly enhance diabetologist training and patient education, prevention, and treatment for Type 1 and Type 2 diabetes.
  • Future research should focus on integrating diverse digital platforms and stakeholder input to advance VR/AR diabetes applications.
  • Early-stage VR diabetes innovations offer advantages and opportunities for improving diabetes training, management, and treatment.